• Alumni

Activity Feed

Great post! WP has really revolutionized the Rx glasses buying process, something that companies like ZenniOptical have tried to do before. I think WP’s success lies in their strategy of really giving consumers the fashion-forward styles they are looking for. That and they are also a higher quality pair than some of the other sites.

I was surprised you didn’t mention their one-for-one social mission. Do you think that is aligned with the rest of their business model?

On December 12, 2015, LH commented on Your doctor is on the line: Teladoc :

Thanks for writing this, Teladoc has a really interesting business model. Do you know what the pricing structure actually is? Is it comparable to having a $50 or $100 co-pay for emergency room visits? Is there any relationship with payers to allow patients to use this with their regular insurance policy? Similarly, who is paying for this? Are employers purchasing the subscription for their employees? It seems as though there could be great benefits for employers that provide this service, ie, healthier employees who lose less working days.

On December 10, 2015, LH commented on McMaster-Carr – Delivering Supplies and Service :

Eliza, I love this post (and you will now know how much of a nerd I really am)! McMaster-Carr is a phenomenal company. I just wanted to add R&D to your target customer list. They are lifesavers both in university and industry settings. In a university lab, being able to get a small number of parts is essential when you’re working on a tight academic budget and may only be trying to build a small prototype. In industry R&D there are still many times you don’t know exactly what will work for your application. I once bought 12 types of foam (which arrived next day!), but each type cost <$5 because they would sell individual sheets. They also stock a ton of useful lab storage items, as lab manager a good 50%+ of the storage space in my lab was outfitted with McMaster-Carr SKUs.

I had no idea the catalog was so coveted, I left mine in my office . . .

On December 6, 2015, LH commented on Flatiron Health: Finding the Cure for Cancer :

Flatiron Health has a really interesting product and seems to be making strides towards effective data collection and analysis. However, I would be very concerned about the confidentiality point raised by Laura above. Adoption of many Health IT solutions has been stagnant due to concerns about how the data will be used, and this is even just with Electronic Health Records that have no direct plans for use in analytics. A significant aspect of Flatiron’s value-add is their utilization of the oncology data they collect but I foresee there being significant resistance from patients and physicians that are concerned about data being leaked or sold.